This post is part of Founder’s Thoughts, a series by Michel Abdel Malek, founder of Delphyr, sharing his perspectives on where healthcare AI is heading, and the decisions required to build responsibly in that future.

As foundation models accelerate and large players enter healthcare, many AI capabilities that once felt transformative are quickly becoming standard. This shift forces an important question: what truly differentiates AI in clinical care once the basics are commoditized? This reflection explores why Delphyr chose a fundamentally different path early on—one grounded in clinical accountability.

In healthcare, many AI workflows were always going to be commoditized. 

From day one at Delphyr, we’ve been clear-eyed about where this space was heading. Ambient listening, deep searching literature, and summarizing clinical notes: these capabilities would inevitably become table stakes once foundation models matured.

Seeing OpenAI and Anthropic enter the healthcare space wasn’t a surprise to us; it was an assumption we built around.

And, that’s exactly why we doubled down early on a medical-grade approach

When AI Moves From Assistance to Clinical Influence

When AI starts to surface patient-specific data and combine it with clinical guidelines, it crosses a meaningful threshold. At that point, you’re no longer just “summarizing and translating” medical information, you’re driving clinical decisions. And anything that shapes clinical pathways carries responsibility.

Clinical Decision Support Requires Clinical Accountability

At Delphyr, we made a deliberate choice to optimize for clinical accountability. We chose to build as a medical tool from the start, with patient safety, regulatory rigor, and real-world clinical use as first-order constraints.

As AI continues to transform healthcare, the real long-term differentiation won’t just come from generic workflows, they will come from solutions that meet the highest clinical efficacy and safety standards. Regulatory standard are technology's guardrails.

That’s the future we’ve been building toward since day one.

Let's talk

If you’re curious about what this shift toward medical-grade AI could mean for your organization, I’d be glad to connect and explore it together.